Jason Moffat

Senior Scientist and Program Head

Hospital for Sick Children
Country flagCanada

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jason Moffat is a Senior Scientist and Program Head at the Hospital for Sick Children in Canada. His research focuses on cancer immunotherapy, nanoparticle technology, and genetic interactions, as demonstrated in his recent articles. With contributions to the understanding of therapeutic vulnerabilities in lung cancer brain metastasis and the development of CRISPR-based methods for protein tagging, he is a leading figure in the field of molecular biology and translational research.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Thomas Kislinger

Professor

University of Toronto

CANADA
View details

Jongmyung Kim

Assistant Professor

University of South Florida

UNITED STATES
View details

Sheila K. Singh

McMaster University

CANADA
View details

Wayne Ngo

University of California, Berkeley

UNITED STATES
View details

Jonathan Weissman

Whitehead Institute for Biomedical Research

UNITED STATES
View details

Mahmoud Labib

Lecturer

University of Plymouth

UNITED KINGDOM
View details

Job Dekker

University of Massachusetts Chan Medical School

UNITED STATES
View details

Ariana Huebner

University College London

UNITED KINGDOM
View details

Kui Zhai

McMaster University

CANADA
View details

Shana Kelley

Professor

Northwestern University

UNITED STATES
View details

Hong Han

Assistant Professor

McMaster University

CANADA
View details

Arvind Singh Mer

University of Ottawa

CANADA
View details

Antoine Dufour

Assistant Professor

University of Calgary

CANADA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.